BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9864033)

  • 1. Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation.
    Cotler SJ; Gaur LK; Gretch DR; Wile M; Strong DM; Bronner MP; Carithers RL; Emond MJ; Perkins JD; Nelson KA
    Tissue Antigens; 1998 Nov; 52(5):435-43. PubMed ID: 9864033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation.
    Belli LS; Zavaglia C; Alberti AB; Poli F; Rondinara G; Silini E; Taioli E; de Carlis L; Scalamogna M; Forti D; Pinzello G; Idèo G
    Hepatology; 2000 Jun; 31(6):1345-50. PubMed ID: 10827162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HLA class II alleles and protection from or susceptibility to chronic hepatitis C.
    Zavaglia C; Martinetti M; Silini E; Bottelli R; Daielli C; Asti M; Airoldi A; Salvaneschi L; Mondelli MU; Ideo G
    J Hepatol; 1998 Jan; 28(1):1-7. PubMed ID: 9537846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia.
    Cramp ME; Carucci P; Underhill J; Naoumov NV; Williams R; Donaldson PT
    J Hepatol; 1998 Aug; 29(2):207-13. PubMed ID: 9722201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance and persistence of hepatitis C virus in a Tunisian population: association with HLA class I and class II.
    Ksiaa L; Ayed-Jendoubi S; Sfar I; Gorgi Y; Najjar HA; Abdallah TB; Ayed K
    Viral Immunol; 2007; 20(2):312-9. PubMed ID: 17603847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.
    Belli LS; Burra P; Poli F; Battista Alberti A; Silini E; Zavaglia C; Fagiuoli S; Prando D; Espadas de Arias A; Boninsegna S; Tinelli C; Scalamogna M; de Carlis L; Pinzello G
    Gastroenterology; 2006 Mar; 130(3):695-702. PubMed ID: 16530511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of HLA class II allele level disparity in unrelated bone marrow transplantation: analysis of 1259 National Marrow Donor Program donor-recipient pairs.
    Hurley CK; Baxter-Lowe LA; Begovich AB; Fernandez-Vina M; Noreen H; Schmeckpeper B; Awdeh Z; Chopek M; Salazar M; Williams TM; Yunis EJ; Kitajima D; Shipp K; Splett J; Winden T; Kollman C; Johnson D; Ng J; Hartzman RJ; Hegland J
    Bone Marrow Transplant; 2000 Feb; 25(4):385-93. PubMed ID: 10723581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of HLA class II alleles with hepatitis C virus clearance and persistence in thalassemia patients from Iran.
    Samimi-Rad K; Sadeghi F; Amirzargar A; Eshraghian MR; Alavian SM; Rahimnia R
    J Med Virol; 2015 Sep; 87(9):1565-72. PubMed ID: 25970464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
    Kuniholm MH; Kovacs A; Gao X; Xue X; Marti D; Thio CL; Peters MG; Terrault NA; Greenblatt RM; Goedert JJ; Cohen MH; Minkoff H; Gange SJ; Anastos K; Fazzari M; Harris TG; Young MA; Strickler HD; Carrington M
    Hepatology; 2010 May; 51(5):1514-22. PubMed ID: 20169624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of HLA class II incompatibility in living donor liver transplantation.
    Campos J; Quijano Y; Franco A; Eiras P; López-Santamaria M; Gámez M; Núño J; Murcia J; López P; Zarzosa G; Garcia M; Albillo A; Bárcena R; Castañer JL; Vicente E
    Transplant Proc; 2003 Aug; 35(5):1888-91. PubMed ID: 12962835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease.
    Yoshizawa K; Ota M; Saito S; Maruyama A; Yamaura T; Rokuhara A; Orii K; Ichijo T; Matsumoto A; Tanaka E; Kiyosawa K
    Tissue Antigens; 2003 Feb; 61(2):159-65. PubMed ID: 12694584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection.
    Yenigün A; Durupinar B
    J Virol; 2002 Feb; 76(4):1787-9. PubMed ID: 11799174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA class II genes determine the natural variance of hepatitis C viral load.
    Fanning LJ; Levis J; Kenny-Walsh E; Whelton M; O'Sullivan K; Shanahan F
    Hepatology; 2001 Jan; 33(1):224-30. PubMed ID: 11124840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HLA class II gene and susceptibility or resistance to chronic hepatitis B.
    Jiang YG; Wang YM; Liu TH; Liu J
    World J Gastroenterol; 2003 Oct; 9(10):2221-5. PubMed ID: 14562382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human leukocyte antigen class I and II alleles on hepatitis C viral load among chronic hepatitis C patients in Southern Taiwan.
    Tseng KC; Tseng CW; Hsieh YH; Chang CK; Lai NS; Hung TH; Chang TT
    Hum Immunol; 2013 Aug; 74(8):978-82. PubMed ID: 23628398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of HLA haplotypes on the clinical courses of individuals infected with hepatitis C virus.
    Kuzushita N; Hayashi N; Moribe T; Katayama K; Kanto T; Nakatani S; Kaneshige T; Tatsumi T; Ito A; Mochizuki K; Sasaki Y; Kasahara A; Hori M
    Hepatology; 1998 Jan; 27(1):240-4. PubMed ID: 9425943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus-related chronic liver disease.
    Asti M; Martinetti M; Zavaglia C; Cuccia MC; Gusberti L; Tinelli C; Cividini A; Bruno S; Salvaneschi L; Ideo G; Mondelli MU; Silini EM
    Hepatology; 1999 Apr; 29(4):1272-9. PubMed ID: 10094975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class II alleles and chronic hepatitis C virus infection.
    Cangussu LOF; Teixeira R; Campos EF; Rampim GF; Mingoti SA; Martins-Filho OA; Gerbase-DeLima M
    Scand J Immunol; 2011 Sep; 74(3):282-287. PubMed ID: 21535077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.